nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—DRD1—Dopamine receptors—DRD2—nicotine dependence	0.0692	0.0908	CbGpPWpGaD
Methylergometrine—HTR1F—Monoamine GPCRs—DRD2—nicotine dependence	0.0276	0.0362	CbGpPWpGaD
Methylergometrine—HTR1E—Monoamine GPCRs—DRD2—nicotine dependence	0.026	0.0341	CbGpPWpGaD
Methylergometrine—HTR1F—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0232	0.0304	CbGpPWpGaD
Methylergometrine—HTR1E—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0219	0.0287	CbGpPWpGaD
Methylergometrine—Pergolide—DRD2—nicotine dependence	0.0192	0.285	CrCbGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0188	0.0247	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0177	0.0233	CbGpPWpGaD
Methylergometrine—Lisuride—DRD2—nicotine dependence	0.0167	0.248	CrCbGaD
Methylergometrine—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.0162	0.0213	CbGpPWpGaD
Methylergometrine—Ergotamine—DRD2—nicotine dependence	0.016	0.238	CrCbGaD
Methylergometrine—DRD1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0157	0.0206	CbGpPWpGaD
Methylergometrine—Bromocriptine—DRD2—nicotine dependence	0.0154	0.229	CrCbGaD
Methylergometrine—DRD1—Monoamine GPCRs—DRD2—nicotine dependence	0.0153	0.0201	CbGpPWpGaD
Methylergometrine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0139	0.0182	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0136	0.0179	CbGpPWpGaD
Methylergometrine—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.0131	0.0172	CbGpPWpGaD
Methylergometrine—DRD1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0129	0.0169	CbGpPWpGaD
Methylergometrine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0124	0.0815	CcSEcCtD
Methylergometrine—HTR1F—GPCR ligand binding—TAS2R16—nicotine dependence	0.0114	0.0149	CbGpPWpGaD
Methylergometrine—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.0114	0.0149	CbGpPWpGaD
Methylergometrine—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.011	0.0144	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—TAS2R16—nicotine dependence	0.0107	0.0141	CbGpPWpGaD
Methylergometrine—Angina pectoris—Varenicline—nicotine dependence	0.0102	0.0672	CcSEcCtD
Methylergometrine—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00955	0.0125	CbGpPWpGaD
Methylergometrine—Bradycardia—Varenicline—nicotine dependence	0.00855	0.0562	CcSEcCtD
Methylergometrine—Hallucination—Varenicline—nicotine dependence	0.00836	0.055	CcSEcCtD
Methylergometrine—HTR1F—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00793	0.0104	CbGpPWpGaD
Methylergometrine—Tinnitus—Varenicline—nicotine dependence	0.00783	0.0515	CcSEcCtD
Methylergometrine—Cardiac disorder—Varenicline—nicotine dependence	0.0078	0.0513	CcSEcCtD
Methylergometrine—HTR1E—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00748	0.00981	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00736	0.00965	CbGpPWpGaD
Methylergometrine—Muscle spasms—Varenicline—nicotine dependence	0.00703	0.0462	CcSEcCtD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00694	0.00911	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.0067	0.00879	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00664	0.00872	CbGpPWpGaD
Methylergometrine—Palpitations—Varenicline—nicotine dependence	0.00646	0.0425	CcSEcCtD
Methylergometrine—HTR1F—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00643	0.00844	CbGpPWpGaD
Methylergometrine—Convulsion—Varenicline—nicotine dependence	0.00634	0.0417	CcSEcCtD
Methylergometrine—DRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00632	0.00829	CbGpPWpGaD
Methylergometrine—Hypertension—Varenicline—nicotine dependence	0.00632	0.0415	CcSEcCtD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0063	0.00827	CbGpPWpGaD
Methylergometrine—Chest pain—Varenicline—nicotine dependence	0.00623	0.0409	CcSEcCtD
Methylergometrine—HTR1E—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00607	0.00796	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00595	0.0078	CbGpPWpGaD
Methylergometrine—Nervous system disorder—Varenicline—nicotine dependence	0.00585	0.0385	CcSEcCtD
Methylergometrine—HTR1F—Signaling by GPCR—TAS2R16—nicotine dependence	0.00584	0.00767	CbGpPWpGaD
Methylergometrine—Tachycardia—Varenicline—nicotine dependence	0.00583	0.0383	CcSEcCtD
Methylergometrine—Hyperhidrosis—Varenicline—nicotine dependence	0.00577	0.0379	CcSEcCtD
Methylergometrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00577	0.00757	CbGpPWpGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—DRD2—nicotine dependence	0.00573	0.00752	CbGpPWpGaD
Methylergometrine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00569	0.00747	CbGpPWpGaD
Methylergometrine—Hypotension—Varenicline—nicotine dependence	0.00558	0.0367	CcSEcCtD
Methylergometrine—HTR1E—Signaling by GPCR—TAS2R16—nicotine dependence	0.00551	0.00723	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—DRD2—nicotine dependence	0.00541	0.00709	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.0054	0.00709	CbGpPWpGaD
Methylergometrine—Dyspnoea—Varenicline—nicotine dependence	0.00532	0.035	CcSEcCtD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00532	0.00698	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—FGD1—nicotine dependence	0.00505	0.00662	CbGpPWpGaD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00502	0.00658	CbGpPWpGaD
Methylergometrine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00488	0.0321	CcSEcCtD
Methylergometrine—DRD1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00487	0.00639	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—OPRM1—nicotine dependence	0.0048	0.0063	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—FGD1—nicotine dependence	0.00476	0.00625	CbGpPWpGaD
Methylergometrine—Abdominal pain—Varenicline—nicotine dependence	0.00472	0.031	CcSEcCtD
Methylergometrine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00469	0.00616	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00468	0.00614	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—FGD1—nicotine dependence	0.00458	0.00602	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00456	0.00598	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—OPRM1—nicotine dependence	0.00453	0.00594	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00443	0.00582	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00433	0.00568	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—FGD1—nicotine dependence	0.00433	0.00567	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0043	0.00564	CbGpPWpGaD
Methylergometrine—Diarrhoea—Varenicline—nicotine dependence	0.00408	0.0268	CcSEcCtD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00408	0.00535	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00403	0.00528	CbGpPWpGaD
Methylergometrine—Dizziness—Varenicline—nicotine dependence	0.00395	0.0259	CcSEcCtD
Methylergometrine—Vomiting—Varenicline—nicotine dependence	0.0038	0.025	CcSEcCtD
Methylergometrine—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00378	0.00497	CbGpPWpGaD
Methylergometrine—Rash—Varenicline—nicotine dependence	0.00376	0.0247	CcSEcCtD
Methylergometrine—Dermatitis—Varenicline—nicotine dependence	0.00376	0.0247	CcSEcCtD
Methylergometrine—Headache—Varenicline—nicotine dependence	0.00374	0.0246	CcSEcCtD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00371	0.00486	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—DRD2—nicotine dependence	0.0036	0.00473	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00357	0.00468	CbGpPWpGaD
Methylergometrine—Nausea—Varenicline—nicotine dependence	0.00355	0.0233	CcSEcCtD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0035	0.00459	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00349	0.00458	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—DRD2—nicotine dependence	0.00347	0.00455	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TAS2R16—nicotine dependence	0.00345	0.00453	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00344	0.00451	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—DRD2—nicotine dependence	0.00327	0.0043	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TAS2R16—nicotine dependence	0.00326	0.00427	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00324	0.00425	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00313	0.0041	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00305	0.00401	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00303	0.00398	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00299	0.00392	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00297	0.0039	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00295	0.00387	CbGpPWpGaD
Methylergometrine—HTR1F—brain—nicotine dependence	0.00295	0.161	CbGeAlD
Methylergometrine—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00282	0.0037	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.0028	0.00367	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00277	0.00364	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.00271	0.00356	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.00271	0.00355	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.0027	0.00354	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00268	0.00352	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.00266	0.00349	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00265	0.00348	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00264	0.00346	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0026	0.00341	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—OPRM1—nicotine dependence	0.00256	0.00336	CbGpPWpGaD
Methylergometrine—HTR1E—brain—nicotine dependence	0.00256	0.139	CbGeAlD
Methylergometrine—HTR1E—Signaling Pathways—FGD1—nicotine dependence	0.00256	0.00335	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.00254	0.00334	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00253	0.00332	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00252	0.00331	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00248	0.00326	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.00246	0.00323	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00245	0.00321	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00241	0.00316	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.0024	0.00314	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.00239	0.00314	CbGpPWpGaD
Methylergometrine—DRD1—midbrain—nicotine dependence	0.00237	0.129	CbGeAlD
Methylergometrine—HTR1E—Signaling by GPCR—OPRM1—nicotine dependence	0.00232	0.00305	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00228	0.00299	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKR1B10—nicotine dependence	0.00226	0.00296	CbGpPWpGaD
Methylergometrine—HTR2B—cardiovascular system—nicotine dependence	0.00222	0.121	CbGeAlD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00219	0.00288	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.00218	0.00285	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00216	0.00284	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00208	0.00273	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.00204	0.00268	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00203	0.00266	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00198	0.0026	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.00196	0.00257	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.00192	0.00253	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.00191	0.00251	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00189	0.00248	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00188	0.00246	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD2—nicotine dependence	0.00185	0.00243	CbGpPWpGaD
Methylergometrine—HTR2C—midbrain—nicotine dependence	0.00184	0.1	CbGeAlD
Methylergometrine—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.00178	0.00234	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.00169	0.00221	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD2—nicotine dependence	0.00168	0.0022	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.00165	0.00216	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00164	0.00215	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.00162	0.00212	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.0016	0.00209	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.00159	0.00209	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—WASF2—nicotine dependence	0.00159	0.00209	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—WASF1—nicotine dependence	0.00152	0.002	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.0015	0.00197	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.0015	0.00197	CbGpPWpGaD
Methylergometrine—DRD1—brain—nicotine dependence	0.00149	0.0812	CbGeAlD
Methylergometrine—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.00146	0.00191	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00145	0.0019	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.00143	0.00188	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00142	0.00187	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.00141	0.00185	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	0.00137	0.0018	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.00137	0.00179	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.00133	0.00174	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.00129	0.00169	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.00129	0.00169	CbGpPWpGaD
Methylergometrine—HTR2A—cardiovascular system—nicotine dependence	0.00118	0.0645	CbGeAlD
Methylergometrine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.00117	0.00153	CbGpPWpGaD
Methylergometrine—HTR2C—brain—nicotine dependence	0.00116	0.0631	CbGeAlD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.00115	0.00151	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.00114	0.00149	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00112	0.00147	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.00112	0.00146	CbGpPWpGaD
Methylergometrine—HTR2B—brain—nicotine dependence	0.00109	0.0592	CbGeAlD
Methylergometrine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	0.00109	0.00143	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD2—nicotine dependence	0.00105	0.00138	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.00105	0.00137	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.00102	0.00133	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD2—nicotine dependence	0.000992	0.0013	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	0.000992	0.0013	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	0.000988	0.0013	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000986	0.00129	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	0.000951	0.00125	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—WASF2—nicotine dependence	0.000935	0.00123	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000931	0.00122	CbGpPWpGaD
Methylergometrine—HTR2A—midbrain—nicotine dependence	0.000925	0.0503	CbGeAlD
Methylergometrine—DRD1—Signaling Pathways—WASF1—nicotine dependence	0.000896	0.00118	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	0.000856	0.00112	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000845	0.00111	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000808	0.00106	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	0.000807	0.00106	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.0008	0.00105	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000767	0.00101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.000734	0.000963	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.000695	0.000911	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.00069	0.000906	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000666	0.000874	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	0.000619	0.000812	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.0006	0.000787	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD2—nicotine dependence	0.000584	0.000766	CbGpPWpGaD
Methylergometrine—HTR2A—brain—nicotine dependence	0.000581	0.0316	CbGeAlD
Methylergometrine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	0.000499	0.000655	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	0.000434	0.000569	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000425	0.000557	CbGpPWpGaD
